A recent study found that the EXO1 expression level was elevated in hepatocellular carcinoma patients and its overexpression was correlated with larger tumor size, increased lymph node metastasis, and thus proving its potential therapeutic value for hepatocellular carcinoma as a promising prognostic marker (Dai et al., 2018). Here, EXO1 is linked to hepatocellular carcinoma.